Optimind Pharma Corp. (OMND.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 02/28
(Values in thousands)
| 08-2025 | 05-2025 | 02-2025 | 11-2024 | 08-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 122 | 106 | 84 | 103 | 90 |
| Receivables | 36 | 61 | 66 | 60 | 79 |
| TOTAL | $158 | $168 | $150 | $163 | $169 |
| Non-Current Assets | |||||
| Investments And Advances | 50 | 50 | 50 | 50 | 50 |
| TOTAL | $50 | $50 | $50 | $50 | $50 |
| Total Assets | $208 | $218 | $200 | $213 | $219 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 121 | 121 | 126 | 126 | 126 |
| TOTAL | $283 | $287 | $275 | $261 | $258 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5 | 0 | 0 | 0 | 0 |
| TOTAL | $5 | $0 | $0 | $0 | $0 |
| Total Liabilities | $288 | $287 | $275 | $261 | $258 |
| Shareholders' Equity | |||||
| Common Shares | 4,799 | 4,799 | 4,793 | 4,793 | 4,793 |
| Retained earnings | -5,050 | -5,039 | -5,039 | -5,012 | -5,003 |
| Other shareholders' equity | 162 | 162 | 162 | 162 | 162 |
| TOTAL | $-80 | $-69 | $-75 | $-48 | $-39 |
| Total Liabilities And Equity | $208 | $218 | $200 | $213 | $219 |